Ultrasis Interactive Healthcare (LSE:ULT): 19/08/2014 good news investors plow in m...

Home > Boards > Other Markets > Foreign Stock Markets > Ultrasis Interactive Healthcare (LSE:ULT)

Followed By	3
Posts	749
Boards Moderated	1
Alias Born	08/25/2010

woolworth

Thursday, November 13, 2014 6:04:54 PM

Re: None

19/08/2014 good news investors plow in more money!!!

http://ultrasisplc.com/news/article/405.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation

Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE MultiStem Ischemic Stroke Study
Mullen Announces Hiring of Richard Curtis to President of International Operations
Molecular Data Inc. Announces ADS Ratio Change
Getlink: ElecLink Goes Live and Looks Forward to Its First Auctions
Deere & Company Down Over 10%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Ross Stores Down Over 21%, on Track for Largest Percent Decrease Since December 1993 -- Data Talk
Macellum Issues Statement Regarding the Kohl’s Board’s Apparent Breach of Fiduciary Duty and Failure to Disclose Material Information Prior to 2022 Annual Meeting
Richemont Shares Fall After Fiscal Year Operating Profit Missed Views, No Resolution Regarding YNAP
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
Jakubowitz Law Reminds Upstart Shareholders of a Lead Plaintiff Deadline of July 12, 2022
BIT Mining Limited to Report First Quarter 2022 Financial Results on May 27, 2022
BAE Systems’ New CV90 Combat Support Vehicles Delivered to Norway
Foghorn Therapeutics Shares Down After FDA Partial Clinical Hold
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®
Evofem Biosciences Announces Pricing of Approximately $26.6 Million Public Offering
AMD Chair and CEO Dr. Lisa Su to Keynote at COMPUTEX 2022
Bank of America Announces 2023 Financial Reporting Dates
ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin (sold as YONDELIS ® by Janssen, a Johnson & Johnson Company) in Connective Tissue Cancer Soft Tissue Sarcoma Mice Study
TJX Companies Down Over 7%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
STOXX Europe 50 Index Ends the Week 1.12% Lower at 3564.81 -- Data Talk

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

Detailed Quote